|
DELIVERY ORDER
|
AWARD
|
75N93023F00001
|
2023-08-28
|
2024-12-31
|
2024-12-31
|
|
| Unique Award Key |
CONT_AWD_75N93023F00001_7529_HHSN272201600006I_7529
|
| Awarding Agency |
Department of Health and Human Services
|
| Link |
View Page
|
Award Amounts
| Obligated Amount |
799780.00 |
| Current Award Amount |
799780.00 |
| Potential Award Amount |
799780.00 |
Description
| Title |
DEVELOPMENT OF LNA14 ANALYTICAL METHODS AND UPSTREAM AND DOWNSTREAM PROCESSES FOR MANUFACTURING, AND SCALE-UP MANUFACTURING AND RELEASE TESTING OF THE PURIFIED LNA14 PRODUCT |
| NAICS Code |
541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| Product and Service Codes |
AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
Recipient Details
| Recipient |
RESILIENCE GOVERNMENT SERVICES, INC. |
| UEI |
GC2RFAZK8G64 |
| Recipient Address |
UNITED STATES, 13200 NW NANO CT, ALACHUA, ESCAMBIA, FLORIDA, 32516 |
|
|
DELIVERY ORDER
|
AWARD
|
W911SR22F0073
|
2022-06-16
|
2025-02-28
|
2025-02-28
|
|
| Unique Award Key |
CONT_AWD_W911SR22F0073_9700_W911SR22D0009_9700
|
| Awarding Agency |
Department of Defense
|
| Link |
View Page
|
Award Amounts
| Obligated Amount |
4861155.86 |
| Current Award Amount |
4861155.86 |
| Potential Award Amount |
4861155.86 |
Description
| Title |
THIS DELIVERY ORDER IS FOR RESEARCH AND DEVELOPMENT TASKS ASSOCIATED WITH DEVELOPING A US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE. |
| NAICS Code |
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Product and Service Codes |
AN42: HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
Recipient Details
| Recipient |
RESILIENCE GOVERNMENT SERVICES, INC. |
| UEI |
GC2RFAZK8G64 |
| Recipient Address |
UNITED STATES, 13200 NW NANO CT, ALACHUA, ALACHUA, FLORIDA, 326158726 |
|
|
DELIVERY ORDER
|
AWARD
|
W911SR22F0014
|
2022-01-04
|
2028-02-29
|
2028-02-29
|
|
| Unique Award Key |
CONT_AWD_W911SR22F0014_9700_W911SR22D0009_9700
|
| Awarding Agency |
Department of Defense
|
| Link |
View Page
|
Award Amounts
| Obligated Amount |
107935343.34 |
| Current Award Amount |
107935344.00 |
| Potential Award Amount |
107935344.00 |
Description
| Title |
THIS REQUIREMENT IS FOR THE DEVELOPMENT OF A U.S. FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE. |
| NAICS Code |
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Product and Service Codes |
AN42: HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
Recipient Details
| Recipient |
RESILIENCE GOVERNMENT SERVICES, INC. |
| UEI |
GC2RFAZK8G64 |
| Recipient Address |
UNITED STATES, 13200 NW NANO CT, ALACHUA, ALACHUA, FLORIDA, 326158726 |
|
|
No data
|
IDV
|
W911SR22D0009
|
2022-01-03
|
No data
|
No data
|
|
| Unique Award Key |
CONT_IDV_W911SR22D0009_9700
|
| Awarding Agency |
Department of Defense
|
| Link |
View Page
|
Award Amounts
| Obligated Amount |
0.00 |
| Potential Award Amount |
249006382.00 |
Description
| Title |
THIS CONTRACT WILL COMPLETE ADVANCED DEVELOPMENT OF THE MONOCLONAL ANTIBODY DRUG PRODUCT, G03-52-01, TO REGULATORY APPROVAL FOR PROPHYLAXIS (POST-EXPOSURE AND/OR PRE-EXPOSURE) TO AEROSOLIZED BOTULINUM NEUROTOXIN A AND B SEROTYPES. |
| NAICS Code |
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Product and Service Codes |
AN42: HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
Recipient Details
| Recipient |
RESILIENCE GOVERNMENT SERVICES, INC. |
| UEI |
GC2RFAZK8G64 |
| Recipient Address |
UNITED STATES, 13200 NW NANO CT, ALACHUA, ALACHUA, FLORIDA, 326158726 |
|
|
DEFINITIVE CONTRACT
|
AWARD
|
75N93019C00057
|
2019-09-09
|
2024-08-11
|
2024-08-17
|
|
| Unique Award Key |
CONT_AWD_75N93019C00057_7529_-NONE-_-NONE-
|
| Awarding Agency |
Department of Health and Human Services
|
| Link |
View Page
|
Award Amounts
| Obligated Amount |
15158703.00 |
| Current Award Amount |
15158703.00 |
| Potential Award Amount |
29026970.00 |
Description
| Title |
PRODUCTION OF A MAB-BASED THERAPEUTIC DIRECTED AGAINST A BROAD SPECTRUM OF HIGHLY DIVERSE BOTULINUM NEUROTOXIN SEROTYPE F SUBTYPES AND DISCOVERY WORK OF MAB AGAINST BOTULINUM NEUROTOXIN SEROTYPE G. |
| NAICS Code |
541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Product and Service Codes |
AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
Recipient Details
| Recipient |
RESILIENCE GOVERNMENT SERVICES, INC. |
| UEI |
GC2RFAZK8G64 |
| Recipient Address |
UNITED STATES, 13200 NW NANO CT, ALACHUA, ALACHUA, FLORIDA, 326158726 |
|
|
DEFINITIVE CONTRACT
|
AWARD
|
W911QY13C0010
|
2013-03-20
|
2023-03-20
|
2023-10-31
|
|
| Unique Award Key |
CONT_AWD_W911QY13C0010_9700_-NONE-_-NONE-
|
| Awarding Agency |
Department of Defense
|
| Link |
View Page
|
Award Amounts
| Obligated Amount |
276824216.26 |
| Current Award Amount |
282290978.35 |
| Potential Award Amount |
366290602.35 |
Description
| Title |
THIS CONTRACT WILL PROVIDE THE DEPARTMENT OF DEFENSE WITH THE ADVANCED DEVELOPMENT AND MANUFACTURING CAPABILITY TO RAPIDLY DEVELOP, APPROVE AND MANUFACTURE MEDICAL COUNTERMEASURES. |
| NAICS Code |
325412: PHARMACEUTICAL PREPARATION MANUFACTURING |
| Product and Service Codes |
AE37: R&D- ECONOMIC GROWTH: MANUFACTURING TECHNOLOGY (COMMERCIALIZED) |
Recipient Details
| Recipient |
RESILIENCE GOVERNMENT SERVICES, INC. |
| UEI |
GC2RFAZK8G64 |
| Recipient Address |
UNITED STATES, 13200 NW NANO CT, ALACHUA, ESCAMBIA, FLORIDA, 32516 |
|
